Home | Corporate

Corporate



The world's leading oral appliance company



SomnoMed was formed in 2004 to commercialise its mandibular advancement splint, the SomnoDent.

We now manufacture and design a premium range of oral appliances for the treatment of Sleep Disordered Breathing (SDB), relieving such conditions as:

  • Obstructive Sleep Apnea
  • Bruxism (Teeth Grinding)


Our Flagship product



Established in 2004 following 7 years of clinical research, we launched the gold standard in oral appliance therapy for the treatment of Obstructive Sleep Apnea.

SomnoMed wholly owns all intellectual property rights to the SomnoDent, which was originally developed by orthodontist Dr Richard Palmisano.


An evidence based approach



We continue to conduct research and development projects to provide further clinical evidence to support the use of our products.

Research is conducted independently at such institutions as the Sydney Dental Hospital and the Royal Prince Alfred Hospital SA. We also have an in-house research and development facility at our head office in Crows Nest, which focuses on adding to our innovative range of oral appliance treaments.


Our global reach



We currently have over 50,000 patients worldwide, under SomnoDent therapy. This number continues to grow with a population that is increasing in weight and age and is seeking modern treatments compatable with their lifestyles.

We now operate in 20 countries throughout the world through our wholly owned subsidiaries in Australia, Singapore, Philippines, Japan, USA and Europe.


A bright future



We continue to grow as we expand globally and are recognised by clinicians as providing safe, clinically proven and effective treatments for SDB patients.












1
. Access Economics 2005, 'Wake up Australia: The value of Healthy Sleep', viewed 16 December 2010,
http://www.accesseconomics.com.au/publicationsreports/search.php?searchfor=mental health

Subscribe for newsletter updates